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Objective—To examine the putative adverse effects of ambient fine particulate matter (PM2.5) 
on brain volumes in older women.
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Methods—We conducted a prospective study of 1403 community-dwelling older women 
without dementia enrolled in the Women's Health Initiative Memory Study (WHIMS), 1996–8. 
Structural brain MRI scans were performed at age of 71–89 years in 2005–6 to obtain volumetric 
measures of gray matter (GM) and normal-appearing white matter (WM). Given residential 
histories and air monitoring data, we used a spatiotemporal model to estimate cumulative PM2.5 
exposure in 1999–2006. Multiple linear regression was employed to evaluate the associations 
between PM2.5 and brain volumes, adjusting for intracranial volumes and potential confounders.
Results—Older women with greater PM2.5 exposures had significantly smaller WM, but not GM 
volumes, independent of geographic region, demographics, socioeconomic status, lifestyles, and 
clinical characteristics including cardiovascular risk factors. For each inter-quartile increment 
(3.49 µg/m3) of cumulative PM2.5 exposure, the average WM volume (95% confidence interval) 
was 6.23 (3.72–8.74) cm3 in the total brain and 4.47 (2.27–6.67) cm3 lower in the association 
areas, equivalent to 1–2 years of brain aging. The adverse PM2.5 effects on smaller WM volumes 
were present in frontal and temporal lobes and corpus callosum (all p-values <0.01). Hippocampal 
volumes did not differ by PM2.5 exposure.
Interpretation—PM2.5 exposure may contribute to WM loss in older women. Future studies are 
needed to determine whether exposures result in myelination disturbance, disruption of axonal 
integrity, damages to oligodendrocytes, or other WM neuropathologies.
Introduction
Evidence is accumulating to support that exposure to ambient air pollutants, especially 
particulate matter (PM), contributes to increased risks and poor outcomes of various 
neurological disorders. Ambient fine particle (PM2.5: PM with aerodynamic diameters < 
2.5µm), an ubiquitous exposure largely generated by combustion processes, has been 
recognized as a pervasive threat to cardiovascular health.1 An increased risk for stroke was 
observable even at relatively low levels of exposures.2–3 Earlier neuroepidemiological 
reports also linked PM to relapses in multiple sclerosis.4 More recent studies reported 
adverse effects of ambient air pollutants on cognitive decline and accelerated brain aging. 
For instance, several cross-sectional studies reported low cognitive performance among 
older people residing in neighborhoods with higher levels of exposure to PM2.55–7 or near 
major roadways.8 Findings from longitudinal studies also support the adverse effect of 
airborne particles on cognitive decline.9–11 Biomarkers of accelerated brain aging in autopsy 
studies were higher among children and young adults living in urban areas with high levels 
of ambient air pollutants.12 As a result, there is growing concern about potential impact of 
ambient air pollution on neurological health.13 Only few studies have begun to examine the 
pathophysiological changes resulting from air pollution exposure. One found that PM2.5 was 
associated with diminished cerebral blood flow,14 but two others reported inconsistent 
associations between PM exposure and white matter hyperintensities.15–16 Importantly, 
many toxicological studies have demonstrated that particle-induced neurotoxicity extends 
beyond cerebrovascular system.17 We examined the neurotoxic effects of PM2.5 on brain 
volumes of older women in the Women’s Health Initiative (WHI) Memory Study (WHIMS). 
We hypothesized that long-term PM2.5 exposures would be associated with smaller brain 
volumes.
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Study Design and Population
The women in our cohort were enrolled in 1996–1998 into the WHIMS, two parallel 
randomized controlled clinical trials of postmenopausal hormone therapy. At WHIMS 
baseline, all women were community-dwelling, aged 65–80 years and free of dementia 
determined by cognitive function tests and clinical evaluations, as part of the WHIMS 
protocols at baseline and annually, described elsewhere.18–19 Briefly, WHIMS implemented 
a four-phase measurement protocol, which included annual screening of global cognitive 
function using the Modified Mini-Mental State Examination20 during each clinic visit. 
Participants who screened positive underwent comprehensive neuropsychological testing 
(including the Consortium to Establish a Registry for Alzheimer’s Disease [CERAD] 
battery), assessment of behavioral symptoms, detailed clinical neurological examination /
neuropsychiatric evaluation, head CAT scan and a series of laboratory tests to rule out 
reversible causes for dementia. A central adjudication committee (2 neurologists and 1 
geriatric psychiatrist) classified the participants as normal, mild cognitive impairment 
(MCI), or dementia. MCI was defined as poor performance (≤10th percentile in CERAD 
norms) on at least one CERAD test, evidence of functional impairment (but not severe 
enough to interfere with activities of daily living), and absence of psychiatric or other 
medical disorders that could explain the cognitive impairment. Dementia was defined by 
DSM-IV criteria (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition). 
In 2005–2006, 1403 participated in the WHIMS Magnetic Resonance Imaging (WHIMS-
MRI) study,21–22 conducted in 14 WHIMS sites. During the 7–10 years of follow-up 
preceding brain MRI scans, 44 participants had been classified as incident MCI and 16 as 
probable dementia (including 6 progressed from MCI). The WHIMS and WHIMS-MRI 
study was approved by the institutional review boards of all participating institutes. Written 
informed consent was obtained from all participants.
WHIMS-MRI Scanning and Data Processing Protocols
All sites followed standardized scan acquisition and processing protocols developed by the 
WHIMS-MRI Quality Control Center, in compliance with the American College of 
Radiology MRI Quality Control Program.22 Briefly, standard T1-, T2-, proton density-
weighted, and FLAIR scans were acquired using 1.5T scanners. T1-weighted volumetric 
MRI scans were pre-processed according to a standardized protocol: 1) alignment to the AC-
PC orientation; 2) removal of extra-cranial material; and 3) segmentation of the brain into 
gray and white parenchyma and cerebrospinal fluid (CSF). Regional volumetric 
measurements of gray matter (GM), white matter (WM), and CSF were subsequently 
obtained via a validated, automated computer-based template warping method.23 This 
technique is based on a digital atlas labeled for brain lobes and individual structures in 92 
anatomic regions of interest (ROIs). The volumes of GM, WM, and CSF of each labeled 
brain region were obtained by summing the number of respective voxels. Intracranial 
volume (ICV) was estimated as the total cerebral hemispheric volumes, including 
ventricular CSF and the CSF within the sulcal spaces. Measures of regional volumes 
obtained by this approach showed high test–retest stability over time.24 To segment small 
vessel ischemic diseases (SVID), a brain lesion segmentation algorithm25–26 was applied to 
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multimodal images (T1, T2 and FLAIR). The computer-assisted methodology was validated 
against manual segmentation used by other cohorts.27 By combining the tissue segmentation 
and lesion segmentation algorithm, every voxel was classified as normal (not SVID-
affected) or abnormal (SVID-affected), allowing calculation of normal-appearing brain 
volumes and SVID volumes in each region. Volumes of GM and WM reported in this article 
referred to normal-appearing brain tissue only. In the present study, ROI analyses focused 
on hippocampus and multimodal association brain areas (frontal, parietal, temporal lobes) 
critical to memory and complex cognitive processing. Data on SVID volumes were also 
acquired to explore their potential influence on the putative adverse PM2.5 exposure effect 
on GM or WM brain structure if any observed.
Estimation of Air Pollution Exposures
WHIMS participants’ residential addresses, prospectively collected at each clinic visit and 
updated at least biannually, were geocoded following a standardized protocol by a single 
geocoding vendor selected from 4 candidates on the basis of its accuracy. Results of 
reliability and validation study with high level of accuracy in geocoding of WHI addresses 
have been published.28 The Bayesian Maximum Entropy (BME)-based spatiotemporal 
modeling approach was employed to estimate the ambient concentration of PM2.5.29 We 
modeled the spatiotemporal interdependence of the environmental data to estimate mean 
trends and covariance of the air pollution fields over time and space, without making strong 
assumptions about the distributions of environmental processes. Our empirical data showed 
that BME estimates of annual exposures were highly correlated (cross-validation 
Spearman’s R=0.90) with the yearly PM2.5 concentrations recorded at the monitoring sites 
of U.S. EPA Air Quality System. This statistically-validated BME model was then applied 
to each geocoded residential location to generate the PM2.5 exposure yearly time-series with 
each estimate anchored on the calendar year. These location-specific exposure estimates 
were then combined with the residential histories including relocations to calculate the 
cumulative PM2.5 exposures. We used time-weighted averages of yearly estimates from 
1999 to 2005–6 when the MRI scan was performed. We were unable to estimate the 
pre-1999 PM2.5 exposures because of limited monitoring data.
Measurement of Covariates
At WHIMS enrollment, participants completed structured questionnaires to provide 
information on: demographics (age, race/ethnicity), socioeconomic status (SES, including 
education, family income, employment status), lifestyle factors (smoking, alcohol 
consumption, physical activity), and clinical characteristics (postmenopausal hormone 
treatment [HT], prior depression, CVD and related risk factors). Body mass index (BMI, in 
kg/m2) was calculated. Hypertension was defined as antihypertensive medication or elevated 
blood pressure (systolic≥140 or diastolic≥90 mmHg). Treated diabetes mellitus (DM) was 
defined as a physician diagnosis plus oral medications or insulin therapy. History of CVD 
included previous coronary heart disease (myocardial infarction, coronary angioplasty, or 
coronary artery bypass graft), stroke, or transient ischemic attack. Good reliability and 
validity of both the self-reported medical histories and the physical measures have been 
documented.30 The Burnam screening algorithm was used to characterize the presence of 
prior depressive disorders.31
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We assessed relationships that cumulative PM2.5 exposures had with women’s 
characteristics, using chi-square tests. Using analysis of covariance (ANCOVA), ICV-
adjusted brain volumes were compared among women grouped by the quartiles of 
cumulative PM2.5 exposures, with p-values accounting for multiple comparisons by the 
Benjamini–Hochberg procedure.32 Statistically significant associations were examined 
further with multiple linear regression to adjust for sociodemographic factors, SES, lifestyle, 
and clinical characteristics. To evaluate the possibility of biases resulting from self-selection 
among participants with better brain health at baseline, we conducted sensitivity analyses by 
adjusting for 3MS score at WHIMS baseline or excluding those (n=54) who had developed 
MCI or dementia prior to MRI scans. To evaluate the possible residual confounding by race/
ethnicity, the adjusted analyses were restricted to non-Hispanic White only. To evaluate 
whether the results were sensitive to missing-at-random assumption in calculating the 
cumulative PM2.5 exposures, we also restricted the analyses to older women with the most 
complete exposure data. Finally, we stratified the effect estimates to assess whether PM2.5 
effects differed by BMI, history of CVDDM, hypertension, or white blood cell count, using 
the tests of interaction. Statistical analyses were performed using the SAS System for 
Windows, Version 9.3 (SAS Institute, Cary, NC).
Results
Tables 1 & 2 describe the cumulative PM2.5 exposures among subgroups of WHIMS-MRI 
participants. Women with cumulative exposures estimated in the upper two quartiles (> 
12.24 µg/m3) were more likely to be ethnic minorities (Black or Hispanic White), less 
physically active (with no moderate or strenuous activities ≥ 20 minutes/week), current 
smokers or diabetic. More detailed comparisons of other population characteristics are 
summarized in Supplementary Materials (Tables 1S; 2S).
ICV-adjusted average brain volumes for women grouped by cumulative PM2.5 exposures 
quartiles are summarized in Table 3. Those in the lowest PM2.5 exposure quartile (<10.67 
µg/m3) on average had the largest normal brain volume, and this pattern persisted in 
association areas of the brain. Differences in brain volumes associated with PM2.5 exposures 
were largely limited to the normal-appearing WM, with no statistically significant 
differences observed in GM. Across the quartile distribution of cumulative PM2.5 exposures, 
the measured total WM volumes (mean±S.D. in cm3) decreased by 3.5% (from 
410.71±50.44 to 396.55±49.30), but ventricular sizes, hippocampal and basal ganglia 
volumes did not differ by PM2.5 exposures. A consistent pattern of smaller WM volume 
with greater PM2.5 exposure was found in the WM of all association areas (frontal; parietal; 
temporal) of the brain (Table 3S).
Results of multiple linear regression models, with additional covariate adjustment, are 
summarized in Table 4. The volume of corpus callosum was included as post-hoc analyses 
in the adjusted models. In order to estimate the PM2.5 effect on each hierarchically-
organized WM volume while accounting for possible confounders, we added covariates 
stepwise (Models A–C in Table 4). The inverse association between PM2.5 exposure and 
WM volumes was present in the total brain, association areas, and corpus callosum. The 
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estimated effect sizes were not materially diminished with multicovariate adjustment. For 
each inter-quartile (3.49 µg/m3) increment of cumulative PM2.5 exposure in the full models 
(Model C: including ICV, geographic region, sociodemographics, SES, lifestyles, HT use, 
depressive symptoms, BMI, CVD and associated risk factors), the adjusted mean of WM 
volume (in cm3) was lowered by 6.23±1.28 in total brain and by 4.47±1.12 in all association 
areas. In our adjusted analyses, these effect estimates were comparable to differences in WM 
volume between WHIMS women who were 1–2 years apart in age. Except for parietal lobe, 
multicovariate-adjusted difference in WM volume across the interquartile range of 
(3.49µg/m3) PM2.5 exposure all reached the pre-determined level of significance (p<0.01) 
for the comparison in frontal lobe (lowered by 2.04±0.59), temporal lobe (lowered by 
1.70±0.33), and corpus callosum (lowered by 0.12±0.04). The distributions of modeled 
residuals (Figure 1) before and after including the cumulative PM2.5 exposure support our 
use of multiple linear region models in these adjusted analyses.
The adverse effects of long-term PM2.5 exposures on WM atrophy remained significant in 
the sensitivity analyses (Table 4S). Further adjusting for baseline 3MS scores or excluding 
subjects who had developed MCI or dementia before the MRI scans resulted in very little 
changes to these effect estimates. In the analyses restricted to non-Hispanic White, there was 
a consistent pattern of PM2.5–smaller WM associations across the brain regions examined, 
with effect estimates comparable to those found in the primary analyses including 
minorities. Despite modest reduction in effect sizes among women with more than 60% 
complete data on the yearly exposure estimates, the presumed PM2.5–associated neurotoxic 
effects on WM atrophy remained statistically significant (p<0.01) for the total brain, 
association areas, and corpus callosum.
In the additional analyses exploring whether SVID could affect the observed associations, 
we found the adverse PM2.5 effects on smaller WM volume was still present across these 
same brain regions (Model E of Table 4S). The resulting effect sizes were not materially 
altered with covariate adjustment for SVID volume in WM, although there was a 
statistically significant (p<0.0001) and negative correlation between SVID in WM and the 
normal-appearing WM volume in all the association brain regions. Furthermore, the 
observed associations were fairly consistent across subgroups defined by BMI, CVD history, 
DM, hypertension, and white blood cell count (Table 5S). Almost all the tests of interactions 
did not reach statistical significance in the examined WM regions (except for parietal WM), 
although greater adverse PM2.5 effects with much smaller WM volumes were found among 
women who were obese (BMI> 30 kg/m2) or had prior CVD. For instance, the association 
of frontal WM with PM2.5 was strongest (–3.04±1.00) in obese women, less (–2.49±0.94) in 
overweight group, and apparently null (–0.34±1.06) in those with BMI<25 kg/m2. Women 
with CVD compared to those with no history, had stronger associations between PM2.5 
exposures and smaller volumes of total brain WM (–8.35±3.42 vs. –5.90±1.37) and frontal 
WM (–3.40±1.57 vs. –1.83±0.63).
Discussions
In this large-scale study of residential exposure to fine particles and human brain structure, 
we found that older women had smaller brain volumes especially in the normal-appearing 
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WM if they resided in places with higher levels of long-term exposure to PM2.5 over 6–7 
years preceding the brain MRI scans. The observed associations were not explained by 
demographic factors, socioeconomic status, lifestyle, and clinical characteristics we 
explored. These novel epidemiologic findings support the emerging concept that late-life 
exposure to ambient particulate air pollutants has a deleterious effect on brain aging.
To the best of our knowledge, only one recent study (N=943) has explored the neurotoxic 
effects of PM exposure on brain volumes.16 Using data from the Framingham Offspring 
Study participants (median age: 68 years; 52% female) in New England and New York 
State, Wilker et al. found smaller total cerebral brain volumes were associated with 
increased residential exposure to PM2.5. The reported exposure-effect, equivalent to one 
year of brain aging in their study, became statistically non-significant after adjusting for 
vascular risk factors (e.g., CVD, DM, and hypertension) that might be associated with long-
term PM2.5 exposure and potentially confound the un-adjusted association. Their analyses 
did not separate the neurotoxic effects on GM vs. WM volumes. The investigators did not 
account for changes in residential locations and used one year of data to represent long-term 
exposure. In the present study, longitudinal data on residential locations allowed us to 
estimate the cumulative PM2.5 exposures over 6–7 years before MRI scans. We discovered 
that the adverse effect on brain structure in older women was primarily driven by smaller 
WM volumes associated with cumulative PM2.5 exposures. These effects were present in the 
WM underlying frontal, parietal, and temporal association regions as well as the corpus 
callosum. The observed neurotoxic effects of long-term PM2.5 exposure on WM volume 
were robust to statistical adjustments for potential confounders including CVD and vascular 
risk factors (Models B&C of Table 4). However, there were no differences in GM or 
hippocampal volumes by PM2.5 exposures. Interestingly, Wilker et al. also reported no 
association between PM2.5 exposure and hippocampal volume.16
Our study findings imply that WM architecture may represent a novel target of particle-
induced neurotoxicity, but the neuroanatomical correlates and metabolic abnormalities in the 
decreased normal-appearing WM are unknown and should be investigated further. For 
instance, myelin-related or axonal biomarkers choline and N-acetylaspartate could be 
assessed by proton magnetic resonance spectroscopy.33 Diffusion tensor images can show 
loss of fractional anisotropy in normal-appearing white matter, but such neuroimaging data 
were not included in the WHIMS MRI protocols. Changes in axial or radial diffusivity in 
diffusion tensor image may shed light on the relative predominance of myelin versus axonal 
injuries.34 Lipid-rich myelin membranes are known to be particularly susceptible to 
oxidative stress, which could be assessed by measuring levels of isoprostanoids in the 
cerebrospinal fluid.35
The underlying mechanism and possible mediators for the pervasive adverse PM2.5 effects 
on WM volumes demonstrated by our study warrant comment. In our exploratory analyses, 
the association between PM2.5 and smaller WM could not be explained by SVID. Since 
SVID includes WM hyperintensities, we observed an expected negative correlation between 
WM and SVID volumes; however, adjustments for SVID did not significantly change our 
findings. This suggests that the mechanisms underlying increased WM hyperintensities 
associated with hypertension and the mechanisms underlying loss of normal-appearing WM 
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related to PM2.5 are likely distinct and independent. Similarly in the Framingham Offspring 
Study,16 adjustment for covert brain infarcts did not alter the association between PM2.5 and 
cerebral brain volume. CVD risk factors and systemic inflammation are known to affect 
WM integrity,36 independent of WM hyperintensities.37–38 Our analyses did not reveal 
statistically significant modification of adverse effects on WM volumes by cardiovascular 
risk factors (Table 5S), but these findings did provide some support for possible mechanistic 
interactions between PM2.5 neurotoxicity and traditional vascular pathways. Stronger 
associations in older women with prior CVD suggested possible interactions of CVD-related 
neurovascular damages with the underlying neuropathology of smaller WM associated with 
PM2.5 exposure. Since the putative adverse effects on WM were still present in older women 
without DM or hypertension, it is more likely that CVD may moderate, but is unlikely to 
mediate, the relationship between PM2.5 and WM loss. We did not assess associations 
between inflammatory markers (IL10, TNF alpha, etc) in this study. Future epidemiologic 
studies are needed to investigate the possible role of low-grade systemic inflammation 
resulting from PM2.5 exposure39 to the WM atrophy. In experimental animals, exposures to 
airborne particles can induce oxidative stress and cause wide-spread neuroinflammation in 
multiple brain regions.40 Female mice exposed to concentrated particles had extensive 
astrocyte activation in corpus callosum.41 PM-induced WM damages, as reflected by 
decreased myelin percentage and reduced size of corpus callosum, was recently 
demonstrated in mice models with early-life exposure to concentrated ambient ultrafine 
particles.42 Neurotoxicological studies using animal models with inhalation exposures may 
help elucidate the underlying neuropathology and mechanistic pathways linking particle 
exposure with WM neurotoxicity.
The neurobehavioral consequences of WM injuries are difficult to predict, since WM tracts 
interconnect widely-distributed cognitive networks. Impaired executive function and 
slowing of cognitive processing speed are often associated with WM hyperintensities,43 
likely due to their predilection to spread centrifugally from the periventricular regions with 
early engagement of longitudinal fasciculi connecting anterior frontal with posterior 
parietal-occipital lobes.44 On the other hand, the observed WM loss associated with PM2.5 
appears to be anatomically diffuse and could potentially impact all cognitive domains. 
Global memory loss associated with PM2.5 exposure was seen in two longitudinal 
studies.10–11 Using data from the Nurses' Health Study Cognitive Cohort, Weuve et al. 
reported memory function declined in older women (70 to 81 years) living in locations with 
higher PM2.5 exposures. Tonne et al. found the adverse PM2.5 effect on memory decline 
among older men and women (N=2687; aged 66± 6 years) enrolled in the Whitehall II 
cohort and residing in greater London.11 However, prior findings from PM epidemiologic 
studies examining the associations of executive function (including working memory and 
attention) and episodic memory were either inconsistent nor non-conclusive. Weuve et al. 
suggested that PM exposure would accelerate the decline of executive functions in older 
women.10 However, results from the longitudinal study on older men (of the Normative 
Aging Study)9 and three cross-sectional analyses6, 8, 45 including men and women did not 
support the hypothesized neurotoxic PM effects on executive function. Two studies (one 
cross-sectional7 and one longitudinal11) showed the association between PM2.5 exposure 
and low performance of episodic memory, but two other longitudinal studies9–10 with 
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instruments assessing episodic memory had not yet reported such findings. We found no 
published data on PM2.5 and information processing speed. These identified data 
inconsistency and knowledge gaps speak to the need for comprehensive analyses with 
longitudinal data on subdomain cognitive declines in air pollution-neuroepidemiology. 
Future studies, especially those planned with integrated analyses of brain imaging and 
cognitive function data, need to put these heterogeneous results in the context of growing 
knowledge about brain morphology in relation to cognitive aging across life span.46
Results of our analyses revealed no statistically significant association between GM volume 
and PM2.5 exposure, consistent with the current toxicological literature with only limited 
evidence for neuronal death in animals with inhaled exposures to concentrated fine 
particles.17 However, interpretation of this observation needs to consider the selected study 
population, exposure characteristics, and analytic approaches. The WHIMS-MRI population 
might remain appropriate for studying late-life (e.g., aged >65) exposure effects on 
accelerated WM loss in advanced ages, because WM volumes of nondemented individuals 
are generally preserved until after age of 50–60 years.47 On the other hand, the age-related 
loss in GM starts in young adulthood,47 and its putative association with PM exposures 
would be better captured had we been able to examine the population before the age of 60–
65. Because our exposure estimation relied exclusively on EPA’s ambient monitoring data, 
the observed associations reflected the adverse effects of PM2.5 exposures from regional 
sources. Therefore, we could not exclude the possibility that smaller GM might be found in 
the elderly exposed to other PM with different profiles of neurotoxicity (e.g., the ultrafine 
particles from vehicular exhausts).48 Also, we only conducted the ROI-based analyses, 
which aggregate the volumetric measures within pre-defined neuroanatomic regions but 
discard the local variation. Future research with finer grained analyses (e.g., using voxel-
based techniques) may be needed to uncover local targets with small-area variations in GM 
if any associated with long-term PM2.5 exposure.
We recognize several limitations to our study. First, our analyses only included one-time 
assessment of brain volume, raising the possibility of reverse causation. Because our 
analyses had already adjusted for SES, lifestyle and various health factors, it was unclear 
what the unmeasured factors were that might have made older women with smaller WM 
volumes live and stay in places with higher PM2.5 exposures. Longitudinal studies with 
repeated brain MRI scans will be needed to address this limitation. Second, because we only 
studied older women, the reported findings may not be generalized to older men or younger 
women. However, it has been shown that sex has negligible effects on the age-related 
change in brain volume in healthy population.49 Third, our study only focused on PM2.5 as a 
regional pollutant, with no information on emission sources, particle constituents, or 
interactions with other pollutant mixtures. Although researches have begun to investigate 
these complexities of PM exposures in the context of cardiopulmonary endpoints, such data 
sources are both costly and also limited for nationwide cohorts. Fourth, our analyses did not 
include genetic determinants of brain structure. Although ApoE allele frequencies vary by 
geographic region,50 there is no clear link between WM volume and ApoE polymorphism 
which does determine the hippocampal volume. Since our analyses did not reveal significant 
associations with hippocampal volumes, it was unlikely that the observed adverse effects of 
PM2.5 on WM volumes were due to confounding by ApoE. Fifth, the employed BME 
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models only allowed us to estimate late-life exposure to PM2.5 after 1999. Since air 
pollution levels have been declining over the past 20 years, previous chronic exposure 
especially during the mid- or earlier life might have different and likely greater adverse 
effects than what observed over 6–7 years before the brain MRI scans. There were several 
notable strengths in our study. Our study was likely the largest neuroimaging study 
conducted in community-dwelling elderly to examine the association between long-term 
PM2.5 exposures and in vivo endophenotype of GM and WM in different regions of aging 
brain. The WHIMS-MRI population was a well-characterized, geographically-diverse 
cohort, providing an optimal environmental context with sufficient exposure gradients to 
study the neurotoxic effects of ambient air pollutants. The comprehensive and high-quality 
WHI covariate data enabled the rigorous adjustment for multiple potential confounders in 
studying air pollution and brain aging.
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Figure 1. Distributions of Multiple Linear Regression Modeled Residuals of Normal-Appearing 
White Matter Total Volumes (†)
†Regressing the brain volumes on fine particulate matter exposure adjusted for multiple 
covariates (Model C of Table 4): before (left) and after (right) including cumulative PM2.5 
exposures.
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